-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師總結如下:威廉斯公司第一季業績穩健,調整後每股收益為0.73美元,高於先前預期的0.62美元,年增22%。調整後EBITDA成長13%至22.5億美元,主要得益於Transco擴建工程、新開發案帶來的墨西哥灣天然氣產量增加、冬季風暴期間倉儲收入的成長。這家專注於天然氣的中游營運商受益於其在液化天然氣基礎設施和資料中心需求方面的戰略地位,並已簽署包括價值23億美元的Neo電力項目和Atlas數據中心基礎設施在內的重要客戶協議。管理階層將2026年成長資本支出預期從先前的61億至67億美元上調至70億至76億美元,同時維持2026年調整後EBITDA預期在80.5億至83.5億美元之間,並預計達到上限。我們認為,積累的成長策略使 WMB 能夠很好地適應長期需求趨勢,儘管第一季資本支出從去年同期的 6.7 億美元增加到 16.4 億美元,這反映了 Transco 和數據中心項目擴張計劃所需的大量投資。
Related Articles
Research Alert: CFRA Retains Buy Rating On Shares Of Vertex Pharmaceuticals Incorporated
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:After Q1 results, we lower our target price to $535 from $579, 24.4x our 2027 EPS, a discount to VRTX's 10-year historical forward P/E average. We maintain our 2026 EPS view of $19.40 and our 2027 EPS estimate at $21.92. VRTX's Q1 2026 was marked by robust revenue growth, successful commercial execution of new products, and significant progress in its clinical pipeline, particularly in the renal space. The company's CF franchise remains the primary revenue driver, while new products like Casgevy and Gernavics are beginning to contribute meaningfully to growth, accounting for approximately 25% of the total product revenue growth in Q1. Pipeline advancement remains robust, in our view, with the completion of the rolling BLA submission for povetacicept in IgA nephropathy representing a significant regulatory milestone. Using a Priority Review Voucher, VRTX expects an expedited six-month FDA review timeline, which is encouraging.
ALS Flags Unauthorized Access to Its IT Systems
ALS (ASX:ALQ) reported a cyber incident involving unauthorized third-party access to some of its information technology (IT) systems, temporarily disrupting parts of its operations, according to a Tuesday Australian bourse filing.The company, with support from external cybersecurity specialists, has implemented containment measures in line with incident response procedures, restoring most operations while continuing targeted remediation in affected areas, per the filing.The company has informed the Australian Cyber Security Center and is investigating the full extent of the breach and its potential data impact, the filing added.
Dexus Secures JV With Boral for Major Ravenhall Logistics Precinct in Melbourne
Dexus (ASX:DXS) has entered a joint venture (JV) with Boral (ASX:BLD) to develop a large-scale logistics precinct in Ravenhall, Melbourne's western corridor, spanning 630 hectares and targeting up to 2.5 million square meters of lettable space, subject to rezoning and regulatory approvals, according to a Tuesday Australian bourse filing.The JV structure gives the company and other capital partners a combined 50% stake, while Boral retains the remaining 50%, with the project developed in staged superlots and supported by substantial third-party capital to enhance capital efficiency, per the filing.The company will oversee rezoning, development, and management, with limited short-term financial impact, while management fees will begin as each stage of investment is completed, the filing added.